Pablo Boixeda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pablo Boixeda has a total of 226 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Alegre-Sanchez
Dermatology Department, Ramon y Cajal Hospital, Madrid, Spain
8 shared publications - Emiliano Grillo
Departamento de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España
5 shared publications Pedro Jaén
Department of Dermatology Ramon y Cajal University Hospital University of Alcalá Madrid Spain
5 shared publications- Leticia Alonso-Castro
Department of Dermatology, Ramón y Cajal University Hospital, Madrid, Spain,
4 shared publications P. Jaén
Department of Dermatology, Ramón y Cajal University Hospital, Madrid, Spain
4 shared publications- Sergio Vano-Galvan
Director de la Unidad de Tricología del Hospital Ramón y Cajal, Madrid, Spain; Unidad de Tricología, Grupo de Dermatología Pedro Jaén, Madrid, Spain
4 shared publications
Latest Publications
- Open Access
Dermatologic Lasers in the Management of Keratinocyte Carcinoma: Lesion-Directed Treatment and Field-Directed Secondary Prevention
Keratinocyte carcinoma (KC) is the most common malignancy worldwide, and its incidence continues to rise. In addition to direct DNA damage, ultraviolet radiation promotes immunosuppression and field cancerisation, thereby contributing to the development of actinic keratoses (AKs) and KC. Against this background, dermatologic lasers have been investigated both for the lesion-directed treatment of selected tumours and for field-directed interventions aimed at reducing the risk of new lesions in chronically photodamaged skin. This narrative review examines the evidence on lasers in KC management, summarising each study by design, numbers of patients and lesions, parameters, outcomes, follow-up and level of evidence. Pulsed dye laser and long-pulsed 1064 nm neodymium-doped yttrium aluminium garnet (Nd:YAG) laser, which differ in mechanism, penetration depth and evidence base, as well as ablative lasers, may be useful in selected low-risk basal cell carcinomas, whereas non-ablative fractional lasers mainly reduce AK burden. Among field-directed approaches, fractional ablative resurfacing shows the strongest evidence for reducing both AK and subsequent KC. However, the evidence remains limited by small studies, heterogeneous protocols, short follow-up, lesion-level analyses and frequent lack of systematic histological confirmation.
Open AccessDermatologic Lasers in the Management of Keratinocyte Carcinoma: Lesion-Directed Treatment and Field-Directed Secondary Prevention
Keratinocyte carcinoma (KC) is the most common malignancy worldwide, and its incidence continues to rise. In addition to direct DNA damage, ultraviolet radiation promotes immunosuppression and field cancerisation, thereby contributing to the development of actinic keratoses (AKs) and KC. Against this background, dermatologic lasers have been investigated both for the lesion-directed treatment of selected tumours and for field-directed interventions aimed at reducing the risk of new lesions in chronically photodamaged skin. This narrative review examines the evidence on lasers in KC management, summarising each study by design, numbers of patients and lesions, parameters, outcomes, follow-up and level of evidence. Pulsed dye laser and long-pulsed 1064 nm neodymium-doped yttrium aluminium garnet (Nd:YAG) laser, which differ in mechanism, penetration depth and evidence base, as well as ablative lasers, may be useful in selected low-risk basal cell carcinomas, whereas non-ablative fractional lasers mainly reduce AK burden. Among field-directed approaches, fractional ablative resurfacing shows the strongest evidence for reducing both AK and subsequent KC. However, the evidence remains limited by small studies, heterogeneous protocols, short follow-up, lesion-level analyses and frequent lack of systematic histological confirmation.
- 9 September 2026
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 52 (11) , e198-e200
Diffuse Dermal Angiomatosis of the Breast Successfully Treated With 595-nm Pulsed Dye Laser
Was not provided for this article.
- 9 September 2026
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 52 (11) , e198-e200
Diffuse Dermal Angiomatosis of the Breast Successfully Treated With 595-nm Pulsed Dye Laser
Was not provided for this article.
- Open Access
- 24 June 2026
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 117 (10) , 104705
Demodicosis: Update and Treatment With Laser and Other Light Sources
- 24 June 2026
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 117 (10) , 104705
Open AccessDemodicosis: Update and Treatment With Laser and Other Light Sources
- 4 December 2025
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 53 (3) , 254-257
Follicular Becker's Nevus: Clinical, Dermoscopic and Histopathological Description of Two Cases and Literature Review
Follicular Becker's nevus (FBN) is a rare variant of Becker's nevus defined by perifollicular pigmentation and folliculocentric distribution. We report two new cases in Caucasian women, aged 22 and 37, with lesions on the breast and lumbar regions. Both presented progressive, asymptomatic hyperpigmented macules since adolescence. Dermoscopy revealed donut‐shaped perifollicular structures with hypopigmented halos surrounded by a reticulated brown network, while histopathology confirmed orthohyperkeratosis, basal pigmentation, elongated rete ridges, and hypertrophic arrector pili muscle bundles. In addition, we reviewed all published FBN cases, highlighting its distinct folliculocentric pattern, predilection for non‐scapular sites, and occurrence beyond Asian cohorts. Both of our patients showed favorable outcomes with picosecond laser therapy, suggesting this approach as a promising treatment option.
- 4 December 2025
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 53 (3) , 254-257
Follicular Becker's Nevus: Clinical, Dermoscopic and Histopathological Description of Two Cases and Literature Review
Follicular Becker's nevus (FBN) is a rare variant of Becker's nevus defined by perifollicular pigmentation and folliculocentric distribution. We report two new cases in Caucasian women, aged 22 and 37, with lesions on the breast and lumbar regions. Both presented progressive, asymptomatic hyperpigmented macules since adolescence. Dermoscopy revealed donut‐shaped perifollicular structures with hypopigmented halos surrounded by a reticulated brown network, while histopathology confirmed orthohyperkeratosis, basal pigmentation, elongated rete ridges, and hypertrophic arrector pili muscle bundles. In addition, we reviewed all published FBN cases, highlighting its distinct folliculocentric pattern, predilection for non‐scapular sites, and occurrence beyond Asian cohorts. Both of our patients showed favorable outcomes with picosecond laser therapy, suggesting this approach as a promising treatment option.
- 12 November 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (7) , 2939-2944
Real‐life experience of a lidocaine/tetracaine self‐occluding topical anesthetic for dermatological procedures
Background: Pliaglis® is a self‐occluding topical anesthetic containing a eutectic mixture of 7% lidocaine and 7% tetracaine, with proven efficacy and safety in several trials.Aims: To evaluate the effectiveness and safety of Pliaglis® for different dermatological procedures in real‐life clinical practice.Methods: This retrospective, multicenter study included 35 patients treated with Pliaglis® prior to five dermatological procedures (pulsed dyed laser, picosecond laser, non‐ablative fractional laser, radiofrequency microneedling, and photodynamic therapy). The primary endpoint was to assess the pain during the procedure with a visual analogue score (VAS) from 0 (no pain) to 10 (most severe pain). Secondary endpoints were the global effectiveness and tolerability (from 0 = very low to 10 = excellent), and the adverse events (AEs) after Pliaglis® removal, classified according to intensity (1–3).Results: The median and mean pain VAS reported by patients was 2 (range 0–9) and 2.9 (±2.3), respectively. More than 65% of the patients had a VAS score ≤3. The effectiveness reported by investigators was “very good” (median 8 [range 2–10], mean 7.5 [±1.9]), which was strongly correlated with the pain VAS reported by patients (Spearman coefficient = ‐ 0.9; p < 0.001). Forty‐five percent of patients reported AEs and they were transient and mostly mild, with a mean intensity score of 1.5 (range 1–3). Tolerability of Pliaglis® was reported by investigators as “excellent” (median 10 [range 1–10], mean 9 [±1.8]).Conclusions: Pliaglis® is an effective topical anesthetic for several dermatological procedures, with an excellent safety and tolerability profile.
- 12 November 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (7) , 2939-2944
Real‐life experience of a lidocaine/tetracaine self‐occluding topical anesthetic for dermatological procedures
Background: Pliaglis® is a self‐occluding topical anesthetic containing a eutectic mixture of 7% lidocaine and 7% tetracaine, with proven efficacy and safety in several trials.Aims: To evaluate the effectiveness and safety of Pliaglis® for different dermatological procedures in real‐life clinical practice.Methods: This retrospective, multicenter study included 35 patients treated with Pliaglis® prior to five dermatological procedures (pulsed dyed laser, picosecond laser, non‐ablative fractional laser, radiofrequency microneedling, and photodynamic therapy). The primary endpoint was to assess the pain during the procedure with a visual analogue score (VAS) from 0 (no pain) to 10 (most severe pain). Secondary endpoints were the global effectiveness and tolerability (from 0 = very low to 10 = excellent), and the adverse events (AEs) after Pliaglis® removal, classified according to intensity (1–3).Results: The median and mean pain VAS reported by patients was 2 (range 0–9) and 2.9 (±2.3), respectively. More than 65% of the patients had a VAS score ≤3. The effectiveness reported by investigators was “very good” (median 8 [range 2–10], mean 7.5 [±1.9]), which was strongly correlated with the pain VAS reported by patients (Spearman coefficient = ‐ 0.9; p < 0.001). Forty‐five percent of patients reported AEs and they were transient and mostly mild, with a mean intensity score of 1.5 (range 1–3). Tolerability of Pliaglis® was reported by investigators as “excellent” (median 10 [range 1–10], mean 9 [±1.8]).Conclusions: Pliaglis® is an effective topical anesthetic for several dermatological procedures, with an excellent safety and tolerability profile.
- 9 November 2021
- Published by Springer Nature in Lasers in Medical Science
- Vol. 37 (4) , 2321-2322
Erythema Ab Igne successfully treated with a 755-nm alexandrite picosecond laser
- 9 November 2021
- Published by Springer Nature in Lasers in Medical Science
- Vol. 37 (4) , 2321-2322
Erythema Ab Igne successfully treated with a 755-nm alexandrite picosecond laser
- 1 July 2020
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 83 (1) , 213-214
Capillary malformation with segmental distribution and central atrophy: A series of 7 cases
- 1 July 2020
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 83 (1) , 213-214
Capillary malformation with segmental distribution and central atrophy: A series of 7 cases
- Open Access
- 1 September 2019
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 110 (7) , 533-545
Documento de consenso español para el algoritmo de tratamiento de la rosácea
- 1 September 2019
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 110 (7) , 533-545
Open AccessDocumento de consenso español para el algoritmo de tratamiento de la rosácea
- 1 June 2019
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 110 (5) , 398-399
FR - Utilidad del láser de colorante pulsado en el lupus eritematoso cutáneo
- 1 June 2019
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 110 (5) , 398-399
FR - Utilidad del láser de colorante pulsado en el lupus eritematoso cutáneo
- 1 March 2019
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 110 (2) , 164-167
Complejo de esclerosis tuberosa asociado a hemihipertrofia y malformaciones vasculares combinadas
- 1 March 2019
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 110 (2) , 164-167
Complejo de esclerosis tuberosa asociado a hemihipertrofia y malformaciones vasculares combinadas